nach oben

Die Ophthalmologie

Erschienen in:

01.04.2022 | Glaukom | CME

Sekundäre Offenwinkelglaukome: Pseudoexfoliationsglaukom, Pigmentglaukom und Neovaskularisationsglaukom

verfasst von: Dr. Roman Greslechner, Prof. Dr. Horst Helbig, Prof. Dr. Detlev Spiegel

Erschienen in: Die Ophthalmologie | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die sekundären Offenwinkelglaukome sind eine heterogene Gruppe von Erkrankungen, bei denen unterschiedliche Pathomechanismen zu einem Anstieg des Augendrucks führen. Dieser Beitrag stellt den ersten Teil einer Übersicht über die häufigsten Formen dar. Die Pathogenese, das typische klinische Erscheinungsbild und die Therapie der Pseudoexfoliations‑, Pigment- und Neovaskularisationsglaukome werden diskutiert. Insbesondere werden Unterschiede in der Behandlung gegenüber den primären Offenwinkelglaukomen herausgearbeitet und – wo möglich – prophylaktische Therapieansätze erörtert.

EGS (2021) European glaucoma society terminology and guidelines for glaucoma, 5th edition. Br J Ophthalmol 105:1–169. https://doi.org/10.1136/bjophthalmol-2021-egsguidelinesCrossRef

Schlötzer-Schrehardt U, Zenkel M (2019) The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma. Exp Eye Res 189:107818. https://doi.org/10.1016/j.exer.2019.107818CrossRefPubMed

Ringvold A, Blika S, Sandvik L (1997) Pseudoexfoliation and mortality. Acta Ophthalmol Scand 75:255–256. https://doi.org/10.1111/j.1600-0420.1997.tb00767.xCrossRefPubMed

Shrum KR, Hattenhauer MG, Hodge D (2000) Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 129:83–86. https://doi.org/10.1016/s0002-9394(99)00255-xCrossRefPubMed

Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124:685–687. https://doi.org/10.1016/s0002-9394(14)70908-0CrossRefPubMed

Karger RA, Jeng SM, Johnson DH et al (2003) Estimated incidence of pseudoexfoliation syndrome and pseudoexfoliation glaucoma in Olmsted County, Minnesota. J Glaucoma 12:193–197. https://doi.org/10.1097/00061198-200306000-00002CrossRefPubMed

Puska PM (2002) Unilateral exfoliation syndrome: conversion to bilateral exfoliation and to glaucoma: a prospective 10-year follow-up study. J Glaucoma 11:517–524. https://doi.org/10.1097/00061198-200212000-00012CrossRefPubMed

Ekström C (1993) Elevated intraocular pressure and pseudoexfoliation of the lens capsule as risk factors for chronic open-angle glaucoma. Acta Ophthalmol 71:189–195. https://doi.org/10.1111/j.1755-3768.1993.tb04989.xCrossRef

Mitchell P, Wang JJ, Hourihan F (1999) The relationship between glaucoma and pseudoexfoliation: the blue mountains eye study. Arch Ophthalmol 117:1319–1324. https://doi.org/10.1001/archopht.117.10.1319CrossRefPubMed

10.

Topouzis F, Harris A, Wilson MR et al (2009) Increased likelihood of glaucoma at the same screening intraocular pressure in subjects with pseudoexfoliation: the Thessaloniki eye study. Am J Ophthalmol 148:606–613.e1. https://doi.org/10.1016/j.ajo.2009.03.024CrossRefPubMed

11.

Ritch R, Schlötzer-Schrehardt U (2001) Exfoliation syndrome. Surv Ophthalmol 45:265–315. https://doi.org/10.1016/s0039-6257(00)00196-xCrossRefPubMed

12.

Helbig H, Schlötzer-Schrehardt U, Noske W et al (1994) Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. Ger J Ophthalmol 3:148–153PubMed

13.

Konstas AGP, Holló G, Irkec M et al (2007) Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study. Br J Ophthalmol 91:757. https://doi.org/10.1136/bjo.2006.106690CrossRefPubMed

14.

Sandhu S, Damji KF (2018) Laser management of glaucoma in exfoliation syndrome. J Glaucoma 27:S91–S94. https://doi.org/10.1097/ijg.0000000000000909CrossRefPubMed

15.

Holló G, Katsanos A, Konstas A‑G (2015) Management of exfoliative glaucoma: challenges and solutions. Clin Ophthalmol 9:907–919. https://doi.org/10.2147/opth.s77570CrossRefPubMedPubMedCentral

16.

Serguhn S, Spiegel D (1999) Vergleich des postoperativen Verlaufes nach Trabekulektomie bei Pseudoexfoliationsglaukom und primärem chronischen Offenwinkelglaukom. Klin Monbl Augenheilkd 215:281–286. https://doi.org/10.1055/s-2008-1034715CrossRefPubMed

17.

Gillies WE, Brooks AM (2002) Central retinal vein occlusion in pseudoexfoliation of the lens capsule. Clin Exp Ophthalmol 30:176–187. https://doi.org/10.1046/j.1442-9071.2002.00513.xCrossRefPubMed

18.

Tojo N, Hayashi A (2021) Ex-Press® versus Baerveldt implant surgery for primary open-angle glaucoma and pseudo-exfoliation glaucoma. Int Ophthalmol 41:1091–1101. https://doi.org/10.1007/s10792-020-01668-yCrossRefPubMed

19.

Ollikainen ML, Puustjärvi TJ, Rekonen PK et al (2011) Mitomycin C‑augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study. Acta Ophthalmol 89:548–555. https://doi.org/10.1111/j.1755-3768.2009.01772.xCrossRefPubMed

20.

Seuthe A‑M, Ivanescu C, Leers S et al (2016) Modified canaloplasty with suprachoroidal drainage versus conventional canaloplasty—1-year results. Graefes Arch Clin Exp Ophthalmol 254:1591–1597. https://doi.org/10.1007/s00417-016-3370-6CrossRefPubMed

21.

Seuthe A‑M, Szurman P, Januschowski K (2020) Canaloplasty with suprachoroidal drainage in patients with pseudoexfoliation glaucoma—four years results. Curr Eye Res 46:1–7. https://doi.org/10.1080/02713683.2020.1795203CrossRef

22.

Puska P, Tarkkanen A (2001) Exfoliation syndrome as a risk factor for cataract development five-year follow-up of lens opacities in exfoliation syndrome. J Cataract Refract Surg 27:1992–1998. https://doi.org/10.1016/s0886-3350(01)00972-5CrossRefPubMed

23.

Ruotsalainen J, Tarkkanen A (1987) Capsule thickness of cataractous lenses with and without exfoliation syndrome. Acta Ophthalmol 65:444–449. https://doi.org/10.1111/j.1755-3768.1987.tb07021.xCrossRef

24.

Jehan FS, Mamalis N, Crandall AS (2001) Spontaneous late dislocation of intraocular lens within the capsular bag in pseudoexfoliation patients. Ophthalmology 108:1727–1731. https://doi.org/10.1016/s0161-6420(01)00710-2CrossRefPubMed

25.

Damji KF, Konstas AGP, Liebmann JM et al (2006) Intraocular pressure following phacoemulsification in patients with and without exfoliation syndrome: a 2 year prospective study. Br J Ophthalmol 90:1014. https://doi.org/10.1136/bjo.2006.091447CrossRefPubMedPubMedCentral

26.

Kristianslund O, Østern AE, Råen M et al (2016) Does cataract surgery reduce the long-term risk of glaucoma in eyes with pseudoexfoliation syndrome? Acta Ophthalmol 94:261–265. https://doi.org/10.1111/aos.12945CrossRefPubMed

27.

Jacobi PC, Dietlein TS, Krieglstein GK (1998) Bimanual trabecular aspiration in pseudoexfoliation glaucoma an alternative in nonfiltering glaucoma surgery. Ophthalmology 105:886–894. https://doi.org/10.1016/s0161-6420(98)95032-1CrossRefPubMed

28.

Ferguson TJ, Swan RJ, Bleeker A et al (2020) Trabecular microbypass stent implantation in pseudoexfoliative glaucoma: long-term results. J Cataract Refract Surg 46:1284–1289. https://doi.org/10.1097/j.jcrs.0000000000000243CrossRefPubMed

29.

Pahlitzsch M, Gonnermann J, Maier A‑K et al (2015) Trabekulotomie ab interno (Trabectome) – Kumulierte klinische Ergebnisse eines großen Glaukomkollektivs. Klin Monbl Augenheilkd 232:1198–1207. https://doi.org/10.1055/s-0041-105941CrossRefPubMed

30.

Iwasaki K, Takamura Y, Orii Y et al (2020) Performances of glaucoma operations with Kahook dual blade or iStent combined with phacoemulsification in Japanese open angle glaucoma patients. Int J Ophthalmol 13:941–945. https://doi.org/10.18240/ijo.2020.06.13CrossRefPubMedPubMedCentral

31.

Siddiqui Y, Hulzen RDT, Cameron JD et al (2003) What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol 135:794–799. https://doi.org/10.1016/s0002-9394(02)02289-4CrossRefPubMed

32.

Scuderi G, Contestabile MT, Scuderi L et al (2019) Pigment dispersion syndrome and pigmentary glaucoma: a review and update. Int Ophthalmol 39:1651–1662. https://doi.org/10.1007/s10792-018-0938-7CrossRefPubMed

33.

Niyadurupola N, Broadway DC (2008) Pigment dispersion syndrome and pigmentary glaucoma—a major review. Clin Exp Ophthalmol 36:868–882. https://doi.org/10.1111/j.1442-9071.2009.01920.xCrossRefPubMed

34.

Karickhoff JR (1992) Pigmentary dispersion syndrome and pigmentary glaucoma: a new mechanism concept, a new treatment, and a new technique. Ophthalmic Surg Lasers Imaging Retina 23:269–277. https://doi.org/10.3928/1542-8877-19920401-11CrossRef

35.

Breingan PJ, Esaki K, Ishikawa H et al (1999) Iridolenticular contact decreases following laser iridotomy for pigment dispersion syndrome. Arch Ophthalmol 117:325–328. https://doi.org/10.1001/archopht.117.3.325CrossRefPubMed

36.

Gupta N, Weinreb RN (1997) New definitions of glaucoma. Curr Opin Ophthalmol 8:38–41. https://doi.org/10.1097/00055735-199704000-00007CrossRefPubMed

37.

Lichter PR, Shaffer RN (1970) Diagnostic and prognostic signs in pigmentary glaucoma. Trans Am Acad Ophthalmol Otolaryngol 74:984–998PubMed

38.

Ritch R, Liebmann J, Robin A et al (1993) Argon laser trabeculoplasty in pigmentary glaucoma. Ophthalmology 100:909–913. https://doi.org/10.1016/s0161-6420(93)31555-1CrossRefPubMed

39.

Ayala M (2014) Long-term outcomes of selective laser trabeculoplasty (SLT) treatment in pigmentary glaucoma patients. J Glaucoma 23:616–619. https://doi.org/10.1097/ijg.0b013e318287abb7CrossRefPubMed

40.

Harasymowycz PJ, Papamatheakis DG, Latina M et al (2005) Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshworks. Am J Ophthalmol 139:1110–1113. https://doi.org/10.1016/j.ajo.2004.11.038CrossRefPubMed

41.

Okafor K, Vinod K, Gedde SJ (2017) Update on pigment dispersion syndrome and pigmentary glaucoma. Curr Opin Ophthalmol 28:154–160. https://doi.org/10.1097/icu.0000000000000352CrossRefPubMed

42.

Setlur VJ, Parikh JG, Rao NA (2010) Changing causes of enucleation over the past 60 years. Graefes Arch Clin Exp Ophthalmol 248:593–597. https://doi.org/10.1007/s00417-009-1262-8CrossRefPubMed

43.

Havens SJ, Gulati V (2015) Neovascular glaucoma. Dev Ophthalmol 55:196–204. https://doi.org/10.1159/000431196CrossRefPubMedPubMedCentral

44.

Lin P‑A, Lee C‑Y, Huang F‑C et al (2020) Trend of neovascular nlaucoma in Taiwan: a 15-year nationwide population-based cohort study. Ophthalmic Epidemiol 27:1–9. https://doi.org/10.1080/09286586.2020.1755445CrossRef

45.

Browning DJ, Scott AQ, Peterson CB et al (1998) The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion. Ophthalmology 105:776–784. https://doi.org/10.1016/s0161-6420(98)95014-xCrossRefPubMed

46.

Blinder KJ, Friedman SM, Mames RN (1995) Diabetic iris neovascularization. Am J Ophthalmol 120:393–395. https://doi.org/10.1016/s0002-9394(14)72173-7CrossRefPubMed

47.

No authors listed (1993) Baseline and early natural history report: the central vein occlusion study. Arch Ophthalmol 111:1087–1095. https://doi.org/10.1001/archopht.1993.01090080083022CrossRef

48.

Tasman W, Magargal LE, Augsburger JJ (1980) Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. Ophthalmology 87:400–402. https://doi.org/10.1016/s0161-6420(80)35225-1CrossRefPubMed

49.

Armaly MF, Baloglou PJ (1967) Diabetes mellitus and the eye: 1. Changes in the anterior segment. Arch Ophthalmol 77:485–492. https://doi.org/10.1001/archopht.1967.00980020487011CrossRefPubMed

50.

Madsen PH (1971) Haemorrhagic glaucoma. Comparative study in diabetic and nondiabetic patients. Br J Ophthalmol 55:444–450. https://doi.org/10.1136/bjo.55.7.444CrossRefPubMedPubMedCentral

51.

Ohrt V (1971) The frequency of rubeosis iridis in diabetic patients. Acta Ophthalmol 49:301–307. https://doi.org/10.1111/j.1755-3768.1971.tb00954.xCrossRef

52.

Nielsen NV (1983) The prevanlence of glaucoma and ocular hypertension in type 1 and 2 diabetes mellitus. An epidemiological study of diabetes mellitus on the island of Falster, Denmark. Acta Ophthalmol 61:662–672. https://doi.org/10.1111/j.1755-3768.1983.tb04357.xCrossRef

53.

Rudkin AK, Lee AW, Chen CS (2010) Ocular neovascularization following central retinal artery occlusion: prevalence and timing of onset. Eur J Ophthalmol 20:1042–1046. https://doi.org/10.1177/112067211002000603CrossRefPubMed

54.

Neupert JR, Brubaker RF, Kearns TP et al (1976) Rapid resolution of venous stasis retinopathy after carotid endarterectomy. Am J Ophthalmol 81:600–602. https://doi.org/10.1016/0002-9394(76)90123-9CrossRefPubMed

55.

Ohnishi Y, Ishibashi T, Sagawa T (1994) Fluorescein gonioangiography in diabetic neovascularisation. Graefes Arch Clin Exp Ophthalmol 232:199–204. https://doi.org/10.1007/bf00184005CrossRefPubMed

56.

Horsley MB, Kahook MY (2010) Anti-VEGF therapy for glaucoma. Curr Opin Ophthalmol 21:112–117. https://doi.org/10.1097/icu.0b013e3283360aadCrossRefPubMed

57.

Wakabayashi T, Oshima Y, Sakaguchi H et al (2008) Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 115:1571–1580.e3. https://doi.org/10.1016/j.ophtha.2008.02.026CrossRefPubMed

58.

Yazdani S, Hendi K, Pakravan M et al (2009) Intravitreal bevacizumab for neovascular glaucoma. J Glaucoma 18:632–637. https://doi.org/10.1097/ijg.0b013e3181997211CrossRefPubMed

59.

Olmos LC, Sayed MS, Moraczewski AL et al (2016) Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab. Eye (Lond) 30:463–472. https://doi.org/10.1038/eye.2015.259CrossRef

60.

Takihara Y, Inatani M, Fukushima M et al (2009) Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol 147:912–918.e1. https://doi.org/10.1016/j.ajo.2008.11.015CrossRefPubMed

61.

Shen CC, Salim S, Du H, Netland PA (2011) Trabeculectomy versus Ahmed glaucoma valve implantation in neovascular glaucoma. Clin Ophthalmol 5:281–286. https://doi.org/10.2147/opth.s16976CrossRefPubMedPubMedCentral

62.

Ghosh S, Singh D, Ruddle JB et al (2010) Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma. Clin Exp Ophthalmol 38:353–357. https://doi.org/10.1111/j.1442-9071.2010.02285.xCrossRefPubMed

63.

Iliev ME, Gerber S (2007) Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 91:1631–1635. https://doi.org/10.1136/bjo.2007.116533CrossRefPubMedPubMedCentral

64.

Murphy CC, Burnett CAM, Spry PGD et al (2003) A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 87:1252. https://doi.org/10.1136/bjo.87.10.1252CrossRefPubMedPubMedCentral

65.

Yildirim N, Yalvac IS, Sahin A et al (2009) A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma. J Glaucoma 18:192–196. https://doi.org/10.1097/ijg.0b013e31817d235cCrossRefPubMed

66.

Strzalkowski P, Strzalkowska A, Göbel W et al (2020) Combined vitrectomy, near-confluent panretinal endolaser, bevacizumab and cyclophotocoagulation for neovascular glaucoma — a retrospective interventional case series. F1000Res 9:1236. https://doi.org/10.12688/f1000research.26879.2CrossRefPubMed

Titel: Sekundäre Offenwinkelglaukome: Pseudoexfoliationsglaukom, Pigmentglaukom und Neovaskularisationsglaukom
verfasst von: Dr. Roman Greslechner
Prof. Dr. Horst Helbig
Prof. Dr. Detlev Spiegel
Publikationsdatum: 01.04.2022
Verlag: Springer Medizin
Schlagwort: Glaukom
Erschienen in: Die Ophthalmologie / Ausgabe 4/2022
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI: https://doi.org/10.1007/s00347-022-01609-3

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Sekundäre Offenwinkelglaukome: Pseudoexfoliationsglaukom, Pigmentglaukom und Neovaskularisationsglaukom

Zusammenfassung

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2022

Unklare beidseitige Visusminderung bei einem 7‑jährigen Jungen

Geteilter Tumor des Ober- und Unterlides

Gorlin-Goltz-Syndrom – nicht nur ein Syndrom maligner Lidtumoren

Intrinsisch photosensitive retinale Ganglienzellen

Junger Mann mit akuter Visusminderung

Neue Variante im ADAMTS10-Gen bei 30‑jähriger Patientin mit Myopie und Engwinkelglaukom

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde